RT Journal Article
SR Electronic
T1 Genetic and environmental determinants of diastolic heart function
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.07.21257302
DO 10.1101/2021.06.07.21257302
A1 Thanaj, Marjola
A1 Mielke, Johanna
A1 McGurk, Kathryn A.
A1 Bai, Wenjia
A1 Savioli, Nicoló
A1 de Marvao, Antonio
A1 Meyer, Hannah V.
A1 Zeng, Lingyao
A1 Sohler, Florian
A1 Wilkins, Martin R.
A1 Ware, James S.
A1 Bender, Christian
A1 Rueckert, Daniel
A1 MacNamara, Aidan
A1 Freitag, Daniel F.
A1 O’Regan, Declan P.
YR 2021
UL http://medrxiv.org/content/early/2021/06/09/2021.06.07.21257302.abstract
AB Diastole is the sequence of physiological events that occur in the heart during ventricular filling and principally depends on myocardial relaxation and chamber stiffness. Abnormal diastolic function is related to many cardiovascular disease processes and is predictive of health outcomes, but its genetic architecture is largely unknown. Here, we use machine learning cardiac motion analysis to measure diastolic functional traits in 39,559 participants of UK Biobank and perform a genome-wide association study. We identified 9 significant, independent loci near genes that are associated with maintaining sarcomeric function under biomechanical stress and genes implicated in the development of cardiomyopathy. Age, sex and diabetes were independent predictors of diastolic function and we found a causal relationship between ventricular stiffness and heart failure. Our results provide novel insights into the genetic and environmental factors influencing diastolic function that are relevant for identifying causal relationships and tractable targets in heart failure.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by Bayer AG; Medical Research Council (MC-A658-5QEB0); National Institute for Health Re-search (NIHR) Imperial College Biomedical Research Centre; British Heart Foundation (NH/17/1/32725, RG/19/6/34387,RE/18/4/34215); Wellcome Trust (107469/Z/15/Z); Academy of Medical Sciences (SGL015/1006); Mason Medical Research Trust grant; and the Engineering and Physical Sciences Research Council (EP/P001009/1). H.V.M. also receives funding from the Simons Center for Quantitative Biology at Cold Spring Harbor Laboratory.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All subjects provided written informed consent for participation in the study, which was also approved by the National Research Ethics Service (11/NW/0382). A statement on research ethics approval for this biobank is available online (https://www.ukbiobank.ac.uk/learn-more-about-uk-biobank/about-us/ethics). Our study was conducted under terms of access approval number 28807 and 40616.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll raw and derived data in this study is available from UK Biobank (http://www.ukbiobank.ac.uk/). GWAS summary level data are publicly available through the GWAS catalogue. https://github.com/ImperialCollegeLondon/diastolic_genetics